陶瓷棒微创技术治疗股骨头无菌性坏死的临床疗效观察
|
摘要
目的分析陶瓷棒微创技术治疗股骨头无菌性坏死的疗效。方法选取行陶瓷棒微创治疗的11例患者。统计手术时间、术中出血量及围术期并发症,术后随访,分析影像学、VAS和Harris评分。结果手术平均时间(55.80±6.30)min、手术出血量30~55 m L。术后随访平均15.6个月。参考Harris评分,优6髋,良5髋。优良率为84.6%,VAS评分与Harris评分术前与术后3个月、术后3个月与6个月比较差异有统计学意义(P<0.05);随访摄片髋关节影像学表现稳定。结论陶瓷棒微创技术治疗股骨头无菌性坏死效果理想。
Objective Analysis of the effect of minimally invasive technique on the treatment of aseptic necrosis of femoral head. Methods 11 patients with ceramic rods minimally invasive treatment. Statistical operation time, intraoperative blood loss and perioperative complications, postoperative follow-up, analysis of imaging, VAS and Harris scores. Results The average operation time(55.80±6.30) min, surgical bleeding 30-55 m L.The mean follow-up was 15.6 months. Reference Harris score, excellent 6 hips, good 5 hips. The excellent and good rate was 84.6%(11/13). There was significant difference between VAS score and Harris score(P<0.05). The follow-up radiography Stable performance. Conclusion The minimally invasive technique of ceramic rods is ideal for the treatment of aseptic necrosis of femoral head.
Objective Analysis of the effect of minimally invasive technique on the treatment of aseptic necrosis of femoral head. Methods 11 patients with ceramic rods minimally invasive treatment. Statistical operation time, intraoperative blood loss and perioperative complications, postoperative follow-up, analysis of imaging, VAS and Harris scores. Results The average operation time(55.80±6.30) min, surgical bleeding 30-55 m L.The mean follow-up was 15.6 months. Reference Harris score, excellent 6 hips, good 5 hips. The excellent and good rate was 84.6%(11/13). There was significant difference between VAS score and Harris score(P<0.05). The follow-up radiography Stable performance. Conclusion The minimally invasive technique of ceramic rods is ideal for the treatment of aseptic necrosis of femoral head.
引文
[1]崔泳,方国正,凯赛尔江·艾合买提,等.富血小板血浆凝胶联合髓芯减压修复兔股骨头无菌性坏死[J].中国组织工程研究,2014(27):4383-4388.
[2]陶伟伟,朱建非,张穹,等.股骨头无菌性坏死中高保留骨量技术应用在初次人工全髋关节置换的临床疗效[J].东南国防医药,2014(2):135-137,156.
[3]刘智华,袁展程,胡庆柳,等.可吸收生物活性骨诱导材料治疗兔股骨头无菌性坏死实验研究[J].国际生物医学工程杂志,2015,38(5):275-277,289.
[4]张普晟,高福芝,李新军,等.股骨头髓芯减压骨内骨推移治疗股骨头无菌性坏死[J].中华损伤与修复杂志,2015(1):70-72.
[5]米树峰.创伤性股骨头坏死的临床治疗效果研究[J].当代医学,2016,22(31):26-27.
[6]邹贵骞,熊川川,温熙.陶瓷股骨头人工全髋关节置换术治疗股骨头缺血坏死的临床效果及安全性观察[J].当代医学,2015,21(7):87-88.
[7]Yang Jie Shan.Progress in treatment of adult femoral head necrosis[J].Chinese Journal of Modern Medicine,2009,11(9):123-125.
[8]Li Xu.Treatment of femoral head necrosis[J].Anhui Medicine,2012,16(1):120-122.
[9]Guo Yueyue.Clinical observation of tantalum rod support in the treatment of early femoral head necrosis[J].Chinese Journal of Nosocomiology,2011,21(1):66-67.
[10]Li Zirong.Total Clinical diagnosis and treatment of femoral head necrosis[J].Chinese Journal of Bone and Joint Surgery,2015,387(1):1-6.
[11]Zhu Shuying.Treatment of steroid-induced femoral head necrosis[J].Medicine and Health:Full Text,2016(10):149.
[12]Deng Yunping,Li Wei.Advances in early treatment of femoral head necrosis[J].Western medicine,2017(2):292-296.
[2]陶伟伟,朱建非,张穹,等.股骨头无菌性坏死中高保留骨量技术应用在初次人工全髋关节置换的临床疗效[J].东南国防医药,2014(2):135-137,156.
[3]刘智华,袁展程,胡庆柳,等.可吸收生物活性骨诱导材料治疗兔股骨头无菌性坏死实验研究[J].国际生物医学工程杂志,2015,38(5):275-277,289.
[4]张普晟,高福芝,李新军,等.股骨头髓芯减压骨内骨推移治疗股骨头无菌性坏死[J].中华损伤与修复杂志,2015(1):70-72.
[5]米树峰.创伤性股骨头坏死的临床治疗效果研究[J].当代医学,2016,22(31):26-27.
[6]邹贵骞,熊川川,温熙.陶瓷股骨头人工全髋关节置换术治疗股骨头缺血坏死的临床效果及安全性观察[J].当代医学,2015,21(7):87-88.
[7]Yang Jie Shan.Progress in treatment of adult femoral head necrosis[J].Chinese Journal of Modern Medicine,2009,11(9):123-125.
[8]Li Xu.Treatment of femoral head necrosis[J].Anhui Medicine,2012,16(1):120-122.
[9]Guo Yueyue.Clinical observation of tantalum rod support in the treatment of early femoral head necrosis[J].Chinese Journal of Nosocomiology,2011,21(1):66-67.
[10]Li Zirong.Total Clinical diagnosis and treatment of femoral head necrosis[J].Chinese Journal of Bone and Joint Surgery,2015,387(1):1-6.
[11]Zhu Shuying.Treatment of steroid-induced femoral head necrosis[J].Medicine and Health:Full Text,2016(10):149.
[12]Deng Yunping,Li Wei.Advances in early treatment of femoral head necrosis[J].Western medicine,2017(2):292-296.